Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 20:13:900489.
doi: 10.3389/fendo.2022.900489. eCollection 2022.

Clinical Characteristics of Patients With HNF1-alpha MODY: A Literature Review and Retrospective Chart Review

Affiliations
Review

Clinical Characteristics of Patients With HNF1-alpha MODY: A Literature Review and Retrospective Chart Review

Qinying Zhao et al. Front Endocrinol (Lausanne). .

Abstract

The clinical manifestation of hepatocyte nuclear factor-1-alpha (HNF1-alpha) maturity-onset diabetes of the young (MODY) is highly variable. This study aims to investigate the clinical characteristics of patients with HNF1-alpha MODY in general, by geographical regions (Asian or non-Asian), HNF1-alpha mutations, and islet autoantibody status. A literature review and a chart review of patients with HNF1-alpha MODY were performed. The means and proportions from studies were pooled using the inverse variance method for pooling, and subgroup analyses were performed. A total of 109 studies involving 1,325 patients [41.5%, 95% confidence interval (CI): 35.2, 48.1; male] were identified. The mean age of diagnosis was 20.3 years (95% CI: 18.3-22.2), and the mean glycated hemoglobin was 7.3% (95% CI: 7.2-7.5). In comparison, Asian patients exhibited significantly higher HbA1c (p = 0.007) and 2-h post-load C-peptide (p = 0.012) levels and lower levels of triglyceride (TG) (p < 0.001), total cholesterol (TC) (p < 0.001), and high-density lipoprotein cholesterol (HDL-c) (p < 0.001) and less often had macrovascular complications (p = 0.014). The age of diagnosis was oldest in patients with mutations in the transactivation domain (p < 0.001). The levels of 2-h post-load C-peptide (p < 0.001), TG (p = 0.007), TC (p = 0.017), and HDL-c (p = 0.001) were highest and the prevalence of diabetic neuropathy was lowest (p = 0.024) in patients with DNA-binding domain mutations. The fasting (p = 0.004) and 2-h post-load glucose (p = 0.003) levels and the prevalence of diabetic neuropathy (p = 0.010) were higher among patients with positive islet autoantibodies. The study demonstrated that the clinical manifestations of HNF1-alpha MODY differed by geographical regions, HNF1-alpha mutations, and islet autoantibody status.

Keywords: HNF1-alpha MODY; HNF1-alpha mutations; diabetes; diabetic complication; pancreatic islet autoantibody.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart.
Figure 2
Figure 2
Distribution of HNF1-alpha mutations. *means nucleotide number and indicates translation stop codon.

References

    1. Fajans SS, Bell GI, Polonsky KS. Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young. N Engl J Med (2001) 345(13):971–80. doi: 10.1056/NEJMra002168 - DOI - PubMed
    1. Passanisi S, Salzano G, Bombaci B, Lombardo F. Clinical and Genetic Features of Maturity-Onset Diabetes of the Young in Pediatric Patients: A 12-Year Monocentric Experience. Diabetol Metab Syndr (2021) 13(1):1–8. doi: 10.1186/s13098-021-00716-6 - DOI - PMC - PubMed
    1. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-Onset Diabetes of the Young (MODY): How Many Cases are We Missing? Diabetologia (2010) 53(12):2504–8. doi: 10.1007/s00125-010-1799-4 - DOI - PubMed
    1. Kyithar MP, Bacon S, Pannu KK, Rizvi SR, Colclough K, Ellard S, et al. . Identification of HNF1A-MODY and HNF4A-MODY in Irish Families: Phenotypic Characteristics and Therapeutic Implications. Diabetes Metab (2011) 37(6):512–9. doi: 10.1016/j.diabet.2011.04.002 - DOI - PubMed
    1. Losekoot M, Broekman A, Breuning M, De Koning E, Romijn J, Maassen J. Molecular Diagnosis on Indication of Maturity Onset Diabetes of the Young; Results From 184 Patients. Nederlands Tijdschrift Voor Geneeskunde. (2005) 149(3):139–43. - PubMed

Publication types

Supplementary concepts